Abstract
The phenomenon of new psychoactive substances (NPS), which came to the attention of the wider international community at the beginning of the 2010s, has been unprecedented in terms of the sheer number of substances, their rate of emergence, chemical diversity, and range of pharmacological effects. In particular, the chemical diversity has been a challenge to promoting a better understanding of the NPS market – a fundamental requirement for effective policy decisions and interventions. This manuscript highlights the significant chemical diversity of NPS and describes an alternative, complementary, and pragmatic classification based on pharmacological effects, which aligns NPS to traditional controlled drugs and enhances understanding of the phenomenon. It further reviews actions taken at the international level to address the NPS issue, including changes in the scope of control of some NPS and the enhancement of the United Nations Early Warning Advisory on NPS to deal with the dynamics and evolution of the market.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- 25B-NBOMe:
-
2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethan-1-amine
- 25C-NBOMe:
-
2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethan-1-amine
- 25I-NBOMe:
-
2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethan-1-amine
- 4,4′-DMAR:
-
4-Methyl-5-(p-tolyl)-4,5-dihydrooxazol-2-amine
- 4Br-alpha-PVP:
-
1-(4-Bromophenyl)-2-(pyrrolidin-1-yl)pentan-1-one
- 4Cl-alpha-PVP:
-
1-(4-Chlorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one
- 4F-alpha-PVP:
-
1-(4-Fluorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one
- 4-MEC:
-
2-Ethylamino-1-(4-methylphenyl)propan-1-one
- 5F-APINACA:
-
N-(Adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide
- Acetylfentanyl:
-
N-(1-Phenethylpiperidin-4-yl)-N-phenylacetamide
- AH-7921:
-
3,4-Dichloro-N-((1-(dimethylamino)cyclohexyl)methyl)benzamide
- alpha-PVP:
-
1-Phenyl-2-(pyrrolidin-1-yl)pentan-1-one
- AM-2201:
-
[1-(5-Fluoropentyl)-1H-indol-3-yl](naphthalen-1-yl)methanone
- APINACA (AKB-48):
-
N-(Adamantan-1-yl)-1-pentyl-1H-indazole-3-carboxamide
- Benzylpiperazine:
-
1-(Phenylmethyl)piperazine
- Butyrfentanyl:
-
N-(1-Phenethylpiperidin-4-yl)-N-phenylbutyramide
- CP-47,497:
-
rel-2-((1R,3S)-3-Hydroxycyclohexyl)-5-(2-methyloctan-2-yl)phenol
- Ethcathinone:
-
2-(Ethylamino)-1-phenylpropan-1-one
- Ethylone:
-
1-(Benzo[d][1,3]dioxol-5-yl)-2-(ethylamino)propan-1-one
- Ethylphenidate:
-
Ethyl-2-phenyl-2-(piperidin-2-yl)acetate
- JWH-018:
-
Naphthalen-1-yl(1-pentyl-1H-indol-3-yl)methanone
- MDMB-CHMICA:
-
Methyl N-{[1-(cyclohexylmethyl)-1H-indol-3-yl]carbonyl}-3-methyl-L-valinate
- MDPV:
-
1-(1,3-Benzodioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one
- Mephedrone:
-
2-(Methylamino)-1-(p-tolyl)propan-1-one
- Methiopropamine:
-
N-Methyl-1-(thiophen-2-yl)propan-2-amine
- Methoxetamine:
-
2-(Ethylamino)-2-(3-methoxyphenyl)cyclohexanone
- Methylone:
-
1-(1,3-Benzodioxol-5-yl)-2-(methylamino)propan-1-one
- MT-45:
-
1-Cyclohexyl-4-(1,2-diphenylethyl)piperazine
- Pentedrone:
-
2-(Methylamino)-1-phenylpentan-1-one
- PMMA:
-
1-(4-Methoxyphenyl)-N-methylpropan-2-amine
- U-47700:
-
3,4-Dichloro-N-((1S,2S)-2-(dimethylamino)cyclohexyl)-N-methylbenzamide
- UR-144:
-
(1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone
- XLR-11:
-
[1-(5-Fluoropentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone
References
97/396/JHA (1997) Joint Action of 16 June 1997 adopted by the Council on the basis of Article K.3 of the Treaty on European Union, concerning the information exchange, risk assessment and the control of new synthetic drugs. http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:31997F0396:EN:HTML. Accessed 27 Feb 2018
Commission on Narcotic Drugs, CND (2012) Report on the fifty-fifth session (13 December 2011 and 12–16 March 2012). http://undocs.org/E/2012/28-E/CN.7/2012/18
Commission on Narcotic Drugs, CND (2013) Resolution 56/4. Enhancing international cooperation in the identification and reporting of new psychoactive substances. http://undocs.org/E/2013/28-E/CN.7/2013/14
Commission on Narcotic Drugs, CND (2014) Challenges and future work in the review of substances for possible scheduling recommendations. Note by the Secretariat. http://undocs.org/E/CN.7/2014/10
Commission on Narcotic Drugs, CND (2015) UNODC-WHO expert consultation on new psychoactive substances, Vienna, 9–11 December 2014. Report by LSS/RAB/DPA/UN. http://undocs.org/E/CN.7/2015/CRP.2
Dargan P, Wood D (2013) Novel psychoactive substances: classification, pharmacology and toxicology. Academic, New York
Ifeagwu SC, Raithelhuber M, Crean C, Gerostamoulos D, Chung H, Tettey JN (2017) Toxicology in international drug control—Prioritizing the most harmful, persistent and prevalent substances. Forensic Sci Int 274:2–6. https://doi.org/10.1016/j.forsciint.2016.11.022
Psychoactive Substances Act (2016) http://www.legislation.gov.uk/ukpga/2016/2/contents/enacted. Accessed 15 Jan 2018
The Misuse of Drugs Act 1971 (Amendment) Order (2009) No. 3209 Article 2. https://www.legislation.gov.uk/uksi/2009/3209/article/2/made. Accessed 15 Jan 2018
United Nations (2013) The international drug control conventions. https://www.unodc.org/documents/commissions/CND/Int_Drug_Control_Conventions/Ebook/The_International_Drug_Control_Conventions_E.pdf. Accessed 22 Jan 2018
United Nations (2016a) Terminology and information on drugs. https://www.unodc.org/documents/scientific/Terminology_and_Information_on_Drugs-3rd_edition.pdf. Accessed 2 Feb 2018
United Nations (2016b) Our joint commitment to effectively addressing and countering the world drug problem. http://undocs.org/A/RES/S-30/1
United Nations (2018) Sustainable development goal 3. https://sustainabledevelopment.un.org/sdg3. Accessed 15 Jan 2018
UNODC (2013a) Recommended methods for the identification and analysis of Piperazines in Seized Materials. https://www.unodc.org/documents/scientific/STNAR47_Piperazines_Ebook.pdf. Accessed 2 Feb 2018
UNODC (2013b) Recommended methods for the identification and analysis of synthetic cannabinoid receptor agonists in seized materials. https://www.unodc.org/documents/scientific/STNAR48_Synthetic_Cannabinoids_ENG.pdf. Accessed 2 Feb 2018
UNODC (2013c) UNODC Global SMART Programme. The challenge of new psychoactive substances. https://www.unodc.org/documents/scientific/NPS_Report.pdf. Accessed 16 Jan 2018
UNODC (2015) Recommended methods for the Identification and Analysis of Synthetic Cathinones in Seized Materials. https://www.unodc.org/documents/scientific/STNAR49_Synthetic_Cathinones_E.pdf. Accessed 2 Feb 2018
UNODC (2016c) Global SMART Update Volume 16. Post-UNGASS .2016: nps trends, challenges, and recommendations. https://www.unodc.org/documents/scientific/Global-SMART-Update-2016-vol-16.pdf. Accessed 15 Jan 2018
UNODC (2016d) New psychoactive substances: overview of trends, challenges and legal approaches. http://undocs.org/E/CN.7/2016/CRP.2
UNODC (2017a) Publications. https://www.unodc.org/unodc/en/scientists/publications-drug-testing-laboratories.html. Accessed 30 Jan 2018
UNODC (2017b) Recommended methods for the identification and analysis of fentanyl and its analogues in biological specimens. https://www.unodc.org/documents/scientific/Recommended_methods_for_the_identification_and_analysis_of_Fentanyl.pdf. Accessed 2 Feb 2018
UNODC (2017c) Global SMART Update Volume 17. Fentanyl and its analogues - 50 years on. https://www.unodc.org/documents/scientific/Global_SMART_Update_17_web.pdf. Accessed 16 Jan 2018
UNODC (2017d) Global SMART Update Volume 18. Non-medical use of benzodiazepines: a growing threat to public health? https://www.unodc.org/documents/scientific/Global_SMART_Update_2017_Vol_18.pdf. Accessed 16 Jan 2018
UNODC (2018a) Early warning advisory on NPS. http://www.unodc.org/nps. Accessed 30 Jan 2018
UNODC (2018b) International drug control conventions. https://www.unodc.org/unodc/en/commissions/CND/conventions.html. Accessed 31 Jan 2018
UNODC (2018c) Early warning advisory toxicology portal. http://www.unodc.org/tox. Accessed 15 Jan 2018
UNODC (2018d) International Collaborative Exercises (ICE) programme. http://www.unodc.org/ice. Accessed 15 Jan 2018
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Tettey, J.N.A., Crean, C., Ifeagwu, S.C., Raithelhuber, M. (2018). Emergence, Diversity, and Control of New Psychoactive Substances: A Global Perspective. In: Maurer, H., Brandt, S. (eds) New Psychoactive Substances . Handbook of Experimental Pharmacology, vol 252. Springer, Cham. https://doi.org/10.1007/164_2018_127
Download citation
DOI: https://doi.org/10.1007/164_2018_127
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-10560-0
Online ISBN: 978-3-030-10561-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)